Trial intelligence / Profile preview

Intravenous versus oral azithromycin for pediatric community-acquired pneumonia

ChiCTR-TRC-14004769Phase 4Completed

Sponsor
Children's Hospital of Fudan University
Start
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of azithromycin in community-acquired pneumonia (CAP) (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoints: Adverse reactions and Efficacy. Started Jul 2014; status: completed.

02

Drugs

azithromycin
03

Conditions

community-acquired pneumonia (CAP)

Beyond the preview

Go deeper on ChiCTR-TRC-14004769.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-14004769.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call